View More Recent Stories

Aug 14, 2024 10:14AM BMO Capital Reiterates Outperform Rating on Neurogene (NGNE)
Aug 12, 2024 06:52AM Neurogene (NGNE) PT Lowered to $49 at H.C. Wainwright
Aug 7, 2024 07:30AM Neurogene (NGNE) Receives RMAT Designation for NGN-401
Jul 12, 2024 07:49AM BMO Capital Reiterates Outperform Rating on Neurogene (NGNE)
Jun 26, 2024 04:04PM BMO Capital Starts Neurogene (NGNE) at Outperform
Jun 11, 2024 05:04AM Baird Starts Neurogene (NGNE) at Outperform
View More Recent Stories